Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DASATINIB”

313 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 313 results

Testing effectiveness (Phase 2)Study completedNCT00820170
What this trial is testing

Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 55
Not applicableStudy completedNCT02389972
What this trial is testing

Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Bristol-Myers Squibb 128
Testing effectiveness (Phase 2)Study completedNCT00364286
What this trial is testing

Therapy of Chronic Lymphocytic Leukemia With Dasatinib (BMS-354825)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 17
Not applicableStudy completedNCT03885830
What this trial is testing

Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients

Who this might be right for
CML, Chronic PhaseCML (Chronic Myelogenous LeukemiaCML - Philadelphia Chromosome+2 more
UNC Lineberger Comprehensive Cancer Center 45
Early research (Phase 1)Study completedNCT02081378
What this trial is testing

A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL

Who this might be right for
Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 326
Testing effectiveness (Phase 2)Ended earlyNCT00780676
What this trial is testing

Personalized Treatment Selection for Metastatic Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 97
Early research (Phase 1)WithdrawnNCT04994561
What this trial is testing

VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

Who this might be right for
Aging
Vitality in Aging Research Group, Inc.
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Early research (Phase 1)Study completedNCT00452673
What this trial is testing

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Bristol-Myers Squibb 52
Testing effectiveness (Phase 2)Study completedNCT00671788
What this trial is testing

A Phase II Evaluation of Dasatinib (Sprycel®, NSC #732517) in the Treatment of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Ended earlyNCT01488318
What this trial is testing

Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Julie E. Bauman, MD, MPH 21
Not applicableStudy completedNCT00382668
What this trial is testing

Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

Who this might be right for
Liver Diseases
Bristol-Myers Squibb 40
Large-scale testing (Phase 3)Study completedNCT00744497
What this trial is testing

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Bristol-Myers Squibb 1,930
Large-scale testing (Phase 3)Ended earlyNCT03079505
What this trial is testing

Dasatinib Versus Nilotinib for Treatment Naïve Chronic Myeloid Leukemia

Who this might be right for
Chronic Myeloid Leukemia - Chronic Phase
Hamad Medical Corporation 10
Testing effectiveness (Phase 2)Ended earlyNCT00817531
What this trial is testing

Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer Patients

Who this might be right for
Breast Cancer
Baylor Breast Care Center 22
Early research (Phase 1)WithdrawnNCT02680951
What this trial is testing

Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Emory University
Not applicableStudy completedNCT02363868
What this trial is testing

Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population

Who this might be right for
Chronic Myeloid Leukemia (CML)
Bristol-Myers Squibb 186
Post-approval studies (Phase 4)UnknownNCT04933526
What this trial is testing

The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients

Who this might be right for
Chronic Myeloid Leukemia in Chronic Phase
Shenzhen Second People's Hospital 118
Early research (Phase 1)WithdrawnNCT03414450
What this trial is testing

Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Ph- Acute Lymphoblastic Leukemia (Ph-ALL)Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+)+1 more
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Testing effectiveness (Phase 2)Study completedNCT01471106
What this trial is testing

Phase II Short-term Adjuvant Therapy and Biomarker Studies With Targeted Agents in Women With Estrogen Receptor Negative Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 26
Next Page